This announcement is a separate document:
迈普医学：关于2024年限制性股票激励计划内幕信息知情人及首次授予激励对象买卖公司股票情况的自查报告
Medprin Regenerative Medical Technologies: Self-inspection report on insider information of the 2024 Restricted Stock Incentive Plan and the buying and selling of company stocks by the first recipients of incentives.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.